pubrio
Asymchem logo

Asymchem

Public
asymchem.com
製薬700+ employeesFounded 1999🇨🇳 中国

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

設立年
1999
従業員数
700+
業種
製薬
企業タイプ
Public Company
株式
sse: 06821.HK
本社
🇨🇳6 Dongting 3rd Avenue, Teda, Tianjin Municipality, Cn, 300457 (+9)
専門分野
製薬バイオテクノロジー化学製造
2 / 3
アクティブな市場
アメリカ合衆国 · イギリス · インド
0
新規市場
信頼度
ほとんどが初期シグナル
+1000%
モメンタム
前期比
33 / 100
拡大スコア
発展中
ステージ3投資中
12 件のシグナル · 過去 90 日間

グローバル展開

ライブ
アメリカ合衆国イギリスインド
ステージ
検討中投資中参入中稼働中

アクティビティパルス

新しいマーケティング・PRのアクティビティ — 11 件の新規シグナルが出現しました。

過去 90 日間
採用
1終了
採用
マーケティング・PR
11新規
広告
プロダクト・技術
0
アクティビティなし
+2さらにカテゴリロック中
5件中3件を表示

市場参入タイムライン

この企業が各市場へ参入した順序 — 古い順から新しい順へ

1
🇺🇸アメリカ合衆国1st 番目に参入した市場 · 2012進行中
投資中
16 件のシグナル投資中 ステージ
2
🇬🇧イギリス2nd 番目に参入した市場 · 2024進行中
投資中
14 件のシグナル投資中 ステージ
3
🇮🇳インド3rd 番目に参入した市場 · 2025進行中
投資中
1 件のシグナル投資中 ステージ
現在のステージ投資中リソースを投入中
信頼度33%
追跡開始2012最初のシグナル

最近のシグナル

広告🇵🇹 ポルトガル4週間前

Asymchem Basel Symposium

広告🇺🇸 アメリカ合衆国4週間前

Asymchem Basel Symposium

登録してシグナルフィードをすべて表示

知っておきたい情報

Asymchem に関するよくある質問

Asymchem の事業、市場、成長シグナルに関する簡潔な回答。

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

今日から旅を始めましょう

まずはプラットフォームでも、まずは会話からでも

Pubrio を自分で使うことも、リサーチ・リード獲得・データ連携を私たちに任せることもできます。

チームに相談
Start Journey Image
pubrio

Pubrio は 50 以上のローカルソースからビジネス・人物・インテントデータを統合し、AI と収益チームに市場全体の可視性を提供します。

© 2026 Pubrio. 無断転載を禁じます。